These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 23377022

  • 1. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation.
    Woehrle NS, Klenotich SJ, Jamnia N, Ho EV, Dulawa SC.
    Psychopharmacology (Berl); 2013 Jun; 227(3):545-51. PubMed ID: 23377022
    [Abstract] [Full Text] [Related]

  • 2. Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation.
    Ho EV, Thompson SL, Katzka WR, Sharifi MF, Knowles JA, Dulawa SC.
    Psychopharmacology (Berl); 2016 Jan; 233(1):57-70. PubMed ID: 26423528
    [Abstract] [Full Text] [Related]

  • 3. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
    Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA, Hen R, Dulawa SC.
    Biol Psychiatry; 2009 Mar 01; 65(5):401-8. PubMed ID: 19013555
    [Abstract] [Full Text] [Related]

  • 4. Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant.
    O'Reilly KC, Connor M, Pierson J, Shuffrey LC, Blakely RD, Ahmari SE, Veenstra-VanderWeele J.
    Psychopharmacology (Berl); 2021 Apr 01; 238(4):1111-1120. PubMed ID: 33511450
    [Abstract] [Full Text] [Related]

  • 5. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA, Velez LP, Masten VL, Dulawa SC.
    Biol Psychiatry; 2011 Dec 01; 70(11):1039-48. PubMed ID: 21920503
    [Abstract] [Full Text] [Related]

  • 6. N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice.
    Allen EM, Hughes EF, Anderson CJ, Woehrle NS.
    Behav Neurosci; 2018 Aug 01; 132(4):258-268. PubMed ID: 29985009
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D, Boulougouris V, Papakosta VM, Kalogerakou S, Papadopoulos S, Poulopoulou C, Papadimitriou GN, Tsaltas E.
    Psychopharmacology (Berl); 2008 Nov 01; 200(4):597-610. PubMed ID: 18622751
    [Abstract] [Full Text] [Related]

  • 8. Ketamine induces immediate and delayed alterations of OCD-like behavior.
    Thompson SL, Welch AC, Iourinets J, Dulawa SC.
    Psychopharmacology (Berl); 2020 Mar 01; 237(3):627-638. PubMed ID: 31927606
    [Abstract] [Full Text] [Related]

  • 9. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex.
    Shalom G, Gur E, Van de Kar LD, Newman ME.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug 01; 370(2):84-90. PubMed ID: 15309378
    [Abstract] [Full Text] [Related]

  • 10. Acute serotonin 1B/1A receptor activation impairs behavioral flexibility in C57BL/6J mice.
    Oliver BL, Burdette MH, Pahua AE, Cavazos C, Morales CA, Alvarez BD, Amodeo DA.
    Behav Brain Res; 2022 Jun 03; 427():113865. PubMed ID: 35367298
    [Abstract] [Full Text] [Related]

  • 11. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Jun 03; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 12. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.
    S N U, J M V, N S J, P V D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1161-6. PubMed ID: 19549549
    [Abstract] [Full Text] [Related]

  • 13. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME, Shalom G, Ran A, Gur E, Van de Kar LD.
    Eur J Pharmacol; 2004 Feb 13; 486(1):25-30. PubMed ID: 14751404
    [Abstract] [Full Text] [Related]

  • 14. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN, Greenslade RG, Cooper J.
    Eur J Pharmacol; 2001 Nov 30; 432(1):19-27. PubMed ID: 11734183
    [Abstract] [Full Text] [Related]

  • 15. Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice.
    Lawson SK, Gray AC, Woehrle NS.
    Behav Brain Res; 2016 Nov 01; 314():52-64. PubMed ID: 27439030
    [Abstract] [Full Text] [Related]

  • 16. Dissecting the roles of β-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice.
    Thompson SL, Dulawa SC.
    PLoS One; 2019 Nov 01; 14(2):e0211239. PubMed ID: 30721232
    [Abstract] [Full Text] [Related]

  • 17. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice.
    Dulawa SC, Hen R, Scearce-Levie K, Geyer MA.
    Psychopharmacology (Berl); 1997 Jul 01; 132(2):125-34. PubMed ID: 9266609
    [Abstract] [Full Text] [Related]

  • 18. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Fontenelle LF, Mendlowicz MV, Versiani M.
    Psychol Med; 2004 Oct 01; 34(7):1367-8; author reply 1368-9. PubMed ID: 15697063
    [No Abstract] [Full Text] [Related]

  • 19. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG, Jensen JB, Sanchez C, Pehrson AL.
    Eur Neuropsychopharmacol; 2014 Jan 01; 24(1):160-71. PubMed ID: 23916504
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior.
    Acosta JI, Boynton FA, Kirschner KF, Neisewander JL.
    Pharmacol Biochem Behav; 2005 Feb 01; 80(2):297-307. PubMed ID: 15680183
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.